Medical device recalls Moderate risk

Roche Diagnostics Corporation recalls Tina-quant IgM Gen.2, Catalog Nos. 03507190190, 05220726190, 03507041190, 03507149190 Product Usage: Immunoturbidimetri…

Recall date
December 17, 2018
Source
U.S. Food & Drug Administration (FDA) — enforcement report
Recall number
Z-1147-2019
FDA classification
Class II
Brand / firm
Roche Diagnostics Corporation
Sold / distributed
US Nationwide distribution.

Why it was recalled

New endogenous interference claims have been established for the following assays used on the cobas c 311 analyzer and the cobas c 501, 502, 701, 702, and Modular Analytics P/D modules which may have potential medical risk. ***Update: Cobas c111 and COBAS INTEGRA 400 plus analyzers are also impacted for BILT3 and LACT2 assays***

Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What was recalled

Tina-quant IgM Gen.2, Catalog Nos. 03507190190, 05220726190, 03507041190, 03507149190 Product Usage: Immunoturbidimetric assay for the quantitative in vitro determination of IgM in human serum and plasma on automated clinical chemistry analyzers analyzers.

Get recall alerts

Free email alert whenever Roche Diagnostics Corporation has a new recall — straight from official government data. Unsubscribe anytime.

More recalls from: Roche Diagnostics Corporation